Aortic stiffness and chronic kidney disease are closely linked by shared risk factors and
associated increased cardiovascular mortality. At lower levels of renal function, aortic stiffness is …

Medial arterial calcification is accelerated in patients with CKD and strongly associated with
increased arterial rigidity and cardiovascular mortality. Recently, a novel in vitro blood test …

Background. Vascular stiffening occurs in normal ageing and is accelerated in chronic
kidney disease (CKD). Vascular calcification contributes to this stiffening and to the high …

Background ACE Inhibitors (ACE-I) and Angiotensin-Receptor Antagonists (ARAs) are
commonly prescribed but can cause acute kidney injury (AKI) during intercurrent illness. Rates of …

Background The risk of severe COVID-19 outcomes in people with immune-mediated
inflammatory diseases and on immune-modifying drugs might not be fully mediated by …

Background It is unknown whether stopping renin-angiotensin system (RAS) inhibitor therapy
in patients with advanced CKD affects outcomes. Methods We studied patients referred to …

Background COVID-19 has been shown to differently affect various demographic and
clinical population subgroups. We aimed to describe trends in absolute and relative COVID-19-…

The Global Burden of Disease, Injuries and Risk Factors study estimates the worldwide
number of men with impaired kidney function at 336 million and the number of women at 417 …

Objective To examine long term cardiorenal outcomes associated with increased
concentrations of creatinine after the start of angiotensin converting enzyme inhibitor/angiotensin …

Measurements of biomechanical properties of arteries have become an important surrogate
outcome used in epidemiological and interventional cardiovascular research. Structural and …